» Articles » PMID: 37213023

A Portable Electrochemical Immunosensor for Ovarian Cancer Uses Hierarchical Microporous Carbon Material from Waste Coffee Grounds

Overview
Journal Mikrochim Acta
Specialties Biotechnology
Chemistry
Date 2023 May 22
PMID 37213023
Authors
Affiliations
Soon will be listed here.
Abstract

A simple label-free electrochemical immunosensor for ovarian cancer (OC) detection was developed using a hierarchical microporous carbon material fabricated from waste coffee grounds (WCG). The analysis method exploited near-field communication (NFC) and a smartphone-based potentiostat. Waste coffee grounds were pyrolyzed with potassium hydroxide and used to modify a screen-printed electrode. The modified screen-printed electrode was decorated with gold nanoparticles (AuNPs) to capture a specific antibody. The modification and immobilization processes were characterized by cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). The sensor had an effective dynamic range of 0.5 to 50.0 U mL of cancer antigen 125 (CA125) tumor marker with a correlation coefficient of 0.9995. The limit of detection (LOD) was 0.4 U mL. A comparison of the results obtained from human serum analysis with the proposed immunosensor and the results obtained from the clinical method confirmed the accuracy and precision of the proposed immunosensor.

Citing Articles

An Unlabeled Electrochemical Immunosensor Uses Poly(thionine) and Graphene Quantum Dot-Modified Activated Marigold Flower Carbon for Early Prostate Cancer Detection.

Cotchim S, Kongkaew S, Thavarungkul P, Kanatharana P, Limbut W Biosensors (Basel). 2024; 14(12).

PMID: 39727854 PMC: 11674062. DOI: 10.3390/bios14120589.


Recent advances in carbon-based materials derived from diverse green biowaste for sensing applications: a comprehensive overview from the perspective of synthesis method and application.

Jasim S, Rachchh N, Pallathadka H, Sanjeevi R, Olegovich Bokov D, Bobonazarovna S RSC Adv. 2024; 14(53):39787-39803.

PMID: 39691222 PMC: 11651345. DOI: 10.1039/d4ra07693a.


Comprehensive analysis of electrochemical biosensors for early ovarian cancer detection.

El-Gammal M, Sayed F, Allam N RSC Adv. 2024; 14(50):37580-37597.

PMID: 39588243 PMC: 11587864. DOI: 10.1039/d4ra05972g.

References
1.
Charkhchi P, Cybulski C, Gronwald J, Wong F, Narod S, Akbari M . CA125 and Ovarian Cancer: A Comprehensive Review. Cancers (Basel). 2020; 12(12). PMC: 7763876. DOI: 10.3390/cancers12123730. View

2.
Shen F, Chen S, Gao Y, Dai X, Chen Q . The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women. Oncotarget. 2017; 8(46):80589-80594. PMC: 5655222. DOI: 10.18632/oncotarget.20384. View

3.
Doubeni C, Doubeni A, Myers A . Diagnosis and Management of Ovarian Cancer. Am Fam Physician. 2016; 93(11):937-44. View

4.
Bayoumy S, Hyytia H, Leivo J, Talha S, Huhtinen K, Poutanen M . Glycovariant-based lateral flow immunoassay to detect ovarian cancer-associated serum CA125. Commun Biol. 2020; 3(1):460. PMC: 7442799. DOI: 10.1038/s42003-020-01191-x. View

5.
Li Y, Wang Z, Luo L, Mu C, Xu J, Feng Q . The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis. Eur Rev Med Pharmacol Sci. 2020; 24(2):604-610. DOI: 10.26355/eurrev_202001_20036. View